Login
Home
Charts
Search
Watchlist
Products

Borosil Scientific Ltd

BOROSCI·NSE
118.52-1.08%Wed, 23 Sept '26 11:17

Borosil Scientific Ltd

BOROSCI
NSE
118.52
-1.08%
|Wed, 23 Sept '26 11:17
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,051Cr
Close
Close Price
118.16
Industry
Industry
Glass & Glass Products
PE
Price To Earnings
24.36
PS
Price To Sales
2.20
Revenue
Revenue
478Cr
Rev Gr TTM
Revenue Growth TTM
11.22%
PAT Gr TTM
PAT Growth TTM
146.77%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
9210011610410310112996107121143107
Growth YoY
Revenue Growth YoY%
19.012.01.811.9-7.93.819.610.611.2
Expenses
ExpensesCr
838897948791113919910411198
Operating Profit
Operating ProfitCr
91218101610175817328
OPM
OPM%
10.312.215.89.415.49.912.85.17.514.222.47.9
Other Income
Other IncomeCr
1112223-42123
Interest Expense
Interest ExpenseCr
111000000000
Depreciation
DepreciationCr
454555555555
PBT
PBTCr
6815712714-4513296
Tax
TaxCr
125243502422
PAT
PATCr
5695949-439274
Growth YoY
PAT Growth YoY%
52.674.3-24.8-8.9-183.9-67.6103.3216.1203.6
NPM
NPM%
5.55.78.24.88.64.26.7-4.42.77.219.04.1
EPS
EPS
0.60.71.10.61.00.51.0-0.50.31.03.10.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
9210011610410310112996107121143107
Growth YoY
Revenue Growth YoY%
19.012.01.811.9-7.93.819.610.611.2
Expenses
ExpensesCr
838897948791113919910411198
Operating Profit
Operating ProfitCr
91218101610175817328
OPM
OPM%
10.312.215.89.415.49.912.85.17.514.222.47.9
Other Income
Other IncomeCr
1112223-42123
Interest Expense
Interest ExpenseCr
111000000000
Depreciation
DepreciationCr
454555555555
PBT
PBTCr
6815712714-4513296
Tax
TaxCr
125243502422
PAT
PATCr
5695949-439274
Growth YoY
PAT Growth YoY%
52.674.3-24.8-8.9-183.9-67.6103.3216.1203.6
NPM
NPM%
5.55.78.24.88.64.26.7-4.42.77.219.04.1
EPS
EPS
0.60.71.10.61.00.51.0-0.50.31.03.10.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
396438467478
Growth
Revenue Growth%
10.76.611.2
Expenses
ExpensesCr
349386405412
Operating Profit
Operating ProfitCr
47536266
OPM
OPM%
11.812.013.313.8
Other Income
Other IncomeCr
4817
Interest Expense
Interest ExpenseCr
3211
Depreciation
DepreciationCr
16181919
PBT
PBTCr
32404353
Tax
TaxCr
814810
PAT
PATCr
23273543
Growth
PAT Growth%
13.829.4146.8
NPM
NPM%
5.96.17.49.0
EPS
EPS
2.63.03.94.8
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
396438467478
Growth
Revenue Growth%
10.76.611.2
Expenses
ExpensesCr
349386405412
Operating Profit
Operating ProfitCr
47536266
OPM
OPM%
11.812.013.313.8
Other Income
Other IncomeCr
4817
Interest Expense
Interest ExpenseCr
3211
Depreciation
DepreciationCr
16181919
PBT
PBTCr
32404353
Tax
TaxCr
814810
PAT
PATCr
23273543
Growth
PAT Growth%
13.829.4146.8
NPM
NPM%
5.96.17.49.0
EPS
EPS
2.63.03.94.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
999
Reserves
ReservesCr
367395432
Current Liabilities
Current LiabilitiesCr
1008793
Non Current Liabilities
Non Current LiabilitiesCr
171715
Total Liabilities
Total LiabilitiesCr
493509549
Current Assets
Current AssetsCr
291310335
Non Current Assets
Non Current AssetsCr
203199214
Total Assets
Total AssetsCr
493509549
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
999
Reserves
ReservesCr
367395432
Current Liabilities
Current LiabilitiesCr
1008793
Non Current Liabilities
Non Current LiabilitiesCr
171715
Total Liabilities
Total LiabilitiesCr
493509549
Current Assets
Current AssetsCr
291310335
Non Current Assets
Non Current AssetsCr
203199214
Total Assets
Total AssetsCr
493509549

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3012043
Investing Cash Flow
Investing Cash FlowCr
-2-115-37
Financing Cash Flow
Financing Cash FlowCr
-16-3-6
Net Cash Flow
Net Cash FlowCr
1210
Free Cash Flow
Free Cash FlowCr
1710616
CFO To PAT
CFO To PAT%
127.8449.2125.1
CFO To EBITDA
CFO To EBITDA%
64.3228.269.6
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3012043
Investing Cash Flow
Investing Cash FlowCr
-2-115-37
Financing Cash Flow
Financing Cash FlowCr
-16-3-6
Net Cash Flow
Net Cash FlowCr
1210
Free Cash Flow
Free Cash FlowCr
1710616
CFO To PAT
CFO To PAT%
127.8449.2125.1
CFO To EBITDA
CFO To EBITDA%
64.3228.269.6

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,0869171,051
Price To Earnings
Price To Earnings
40.626.524.4
Price To Sales
Price To Sales
2.52.02.2
Price To Book
Price To Book
2.72.12.4
EV To EBITDA
EV To EBITDA
20.614.716.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
46.147.248.448.4
OPM
OPM%
11.812.013.313.8
NPM
NPM%
5.96.17.49.0
ROCE
ROCE%
8.710.09.89.8
ROE
ROE%
6.36.67.87.8
ROA
ROA%
4.85.36.36.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,0869171,051
Price To Earnings
Price To Earnings
40.626.524.4
Price To Sales
Price To Sales
2.52.02.2
Price To Book
Price To Book
2.72.12.4
EV To EBITDA
EV To EBITDA
20.614.716.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
46.147.248.448.4
OPM
OPM%
11.812.013.313.8
NPM
NPM%
5.96.17.49.0
ROCE
ROCE%
8.710.09.89.8
ROE
ROE%
6.36.67.87.8
ROA
ROA%
4.85.36.36.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Borosil Scientific Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/l4j7u06jw6uq3ifsm13w94sq.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/jygrk03eihvr0dx4ffr1lt6i.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/qr7vqdaac8umcjsgw6ufvcqm.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/56wet6igisl18x3sxci3qmqi.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/hint783p982kuv1tukcpsmqd.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/9ea44syzq75l50a2o6weeter.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/8gxen3c132rxhpxynpskyu5g.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/axwygglnk03559fjud7jek0u.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/qv9z19omtorf3prbfoo9rivd.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/rs8bsa49bqw0e5njer88dpav.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/2oawxq6h8jzppqvqzbosium1.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/nko6lfy9isto1oypk52g1uyf.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/mqym6dswl7oarvrj53adi3e9.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/y6tj3fwq3shd6r44aat4hve5.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/qoxz1u9ckqz7mxg39rsjvi26.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/oetp0ekqv5gbgxxhsfohz25y.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/v87enyhdr4w8r7v5u2e8fmol.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/xm8nq378xq12zftc7il53rcd.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/48ek3enbds8usgjefqbs1h0g.pdf